Musculoskeletal Research Unit, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, United Kingdom.
PLoS One. 2023 Apr 28;18(4):e0284406. doi: 10.1371/journal.pone.0284406. eCollection 2023.
For many people with advanced osteoarthritis, total knee replacement is an effective treatment to relieve pain and improve function. However, 10-34% of people experience chronic postsurgical pain in the months and years after total knee replacement. The Support and Treatment After Replacement (STAR) randomised controlled trial (ISCRTN92545361) evaluated the clinical- and cost-effectiveness of a new multifaceted and personalised care pathway, compared with usual care, for people with pain at three months after total knee replacement. Our objective was to identify factors promoting or inhibiting its implementation, and to inform future training and wider implementation of the pathway. We conducted a prospective process evaluation using qualitative interviews with eight Extended Scope Practitioners and six Principal Investigators from seven trial sites who were involved in delivering the STAR care pathway during the trial. We used Normalization Process Theory as a theoretical framework for qualitative data collection and content analysis. We identified that factors promoting the implementation of the pathway were quick familiarisation with the pathway, valuing patient-centredness, formalising referral processes, and increasing confidence to address neuropathic pain. Challenges to implementation were availability of time and resources, sensitivity in referral process, and ensuring collective understanding of the pathway. These findings have enabled us to make recommendations about the future implementation of the STAR care pathway and will inform the development of a training package, and updated manual for successful delivery in usual care. Furthermore, this model of care has potential value in diverse elective surgeries and pain conditions.
对于许多患有晚期骨关节炎的人来说,全膝关节置换术是一种有效缓解疼痛和改善功能的治疗方法。然而,10-34%的人在全膝关节置换术后的数月和数年内会经历慢性术后疼痛。支持和置换后治疗(STAR)随机对照试验(ISCRTN92545361)评估了一种新的多方面个性化护理途径与常规护理相比,在全膝关节置换术后三个月时对疼痛患者的临床和成本效益。我们的目的是确定促进或抑制其实施的因素,并为未来的培训和更广泛的途径实施提供信息。我们使用定性访谈对来自七个试验点的八名扩展范围从业者和六名主要研究者进行了前瞻性过程评估,这些人在试验期间参与了 STAR 护理途径的提供。我们使用规范化进程理论作为定性数据收集和内容分析的理论框架。我们发现,促进途径实施的因素是快速熟悉途径、重视以患者为中心、正式转诊流程以及增强处理神经病理性疼痛的信心。实施方面的挑战包括时间和资源的可用性、转诊过程的敏感性以及确保对途径的集体理解。这些发现使我们能够就 STAR 护理途径的未来实施提出建议,并为成功实施常规护理提供培训包和更新手册提供信息。此外,这种护理模式在各种择期手术和疼痛状况中具有潜在价值。